Literature DB >> 17895306

Marked inflammation in catastrophic longitudinal myelitis associated with systemic lupus erythematosus.

A C Heinlein1, E Gertner.   

Abstract

Catastrophic longitudinal myelitis is an extremely rare neurologic manifestation of collagen vascular disease, described heretofore in 11 cases of SLE and 1 of Sjogren's Syndrome. This report documents markedly abnormal and worsening CSF findings on sequential CSF examinations over a period of three days (WBC >1500 cells/microL, >80% neutrophils, markedly elevated protein, and extremely low glucose levels) in the absence of infection. These abnormalities cleared rapidly with institution of immunosuppressive therapy so that a third CSF exam done within three days revealed almost complete normalization of CSF values. These findings suggest that in some cases of CLM a strong inflammatory component may be present, while in others, other pathogenic factors may predominate.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17895306     DOI: 10.1177/0961203307081846

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  10 in total

Review 1.  Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations.

Authors:  George K Bertsias; Dimitrios T Boumpas
Journal:  Nat Rev Rheumatol       Date:  2010-05-11       Impact factor: 20.543

2.  Initial presentation of acute transverse myelitis in systemic lupus erythematosus: demographics, diagnosis, management and comparison to idiopathic cases.

Authors:  Steffan W Schulz; Max Shenin; Amy Mehta; Amal Kebede; Marshall Fluerant; Chris T Derk
Journal:  Rheumatol Int       Date:  2011-07-22       Impact factor: 2.631

Review 3.  Lupoid sclerosis.

Authors:  Briele Keiserman; Luiz Fernando Garcias da Silva; Mauro W Keiserman; Carlos Alberto von Mühlen; Henrique Luiz Staub
Journal:  Rheumatol Int       Date:  2009-10-14       Impact factor: 2.631

4.  Rituximab in the treatment of severe lupus myelopathy.

Authors:  Yan Ye; Jie Qian; Yueying Gu; Xiaoqing Chen; Shuang Ye
Journal:  Clin Rheumatol       Date:  2011-02-23       Impact factor: 2.980

5.  Longitudinal extensive transverse myelitis: a rare neurological complication of systemic lupus erythematosus.

Authors:  Sara Seyedali; Deborah R Alpert
Journal:  BMJ Case Rep       Date:  2019-04-25

Review 6.  Longitudinal extensive transverse myelitis--it's not all neuromyelitis optica.

Authors:  Corinna Trebst; Peter Raab; Elke Verena Voss; Paulus Rommer; Mazen Abu-Mugheisib; Uwe K Zettl; Martin Stangel
Journal:  Nat Rev Neurol       Date:  2011-11-01       Impact factor: 42.937

Review 7.  Neuropsychiatric manifestations in systemic lupus erythematosus: epidemiology, pathophysiology and management.

Authors:  Mariana Postal; Lilian T L Costallat; Simone Appenzeller
Journal:  CNS Drugs       Date:  2011-09-01       Impact factor: 5.749

8.  A case of neuropsychiatric lupus Erythematosus characterized by the Owl's eye sign: a case report.

Authors:  Bolin Hu; Pengcheng Wu; Yibiao Zhou; Yan Peng; Xiaoping Tang; Weijiang Ding; Ming Zhang; Xueliang Qi
Journal:  BMC Neurol       Date:  2017-06-29       Impact factor: 2.474

9.  Clinical features and prognoses of acute transverse myelitis in patients with systemic lupus erythematosus.

Authors:  Soo Min Ahn; Seokchan Hong; Doo-Ho Lim; Byeongzu Ghang; Yong-Gil Kim; Chang-Keun Lee; Bin Yoo
Journal:  Korean J Intern Med       Date:  2018-01-05       Impact factor: 2.884

Review 10.  Insights into the role of neutrophils in neuropsychiatric systemic lupus erythematosus: Current understanding and future directions.

Authors:  Tao Ming Sim; Anselm Mak; Sen Hee Tay
Journal:  Front Immunol       Date:  2022-08-09       Impact factor: 8.786

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.